GNTA

$0.00

(

+0.00%

)
Quote details

stock

Genenta Science SpA ADR

NASDAQ | GNTA

3.47

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 13, 2025)

$59.44M

Market Cap

-

P/E Ratio

-0.55

EPS

$6.30

52 Week High

$2.56

52 Week Low

HEALTHCARE

Sector

GNTA Chart

Recent Chart
Price Action

GNTA Technicals

Tags:

GNTA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (EUR)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$9.8M
Selling General And Administrative $5M
Research And Development $4.8M
Operating Expenses $9.8M
Investment Income Net -
Net Interest Income $81K
Interest Income $81K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $45K
Income Before Tax -$8.9M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$8.9M
Comprehensive Income Net Of Tax -
Ebit -$9.8M
Ebitda -$9.7M
Net Income -$8.9M

Revenue & Profitability

Earnings Performance

GNTA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (EUR)
Total Assets $15M
Total Current Assets $14M
Cash And Cash Equivalents At Carrying Value $4.6M
Cash And Short Term Investments $4.6M
Inventory -
Current Net Receivables $1.4M
Total Non Current Assets $351K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $88K
Intangible Assets Excluding Goodwill $88K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $8.1M
Other Current Assets $365K
Other Non Current Assets -
Total Liabilities $2.3M
Total Current Liabilities $2.1M
Current Accounts Payable $318K
Deferred Revenue -
Current Debt -
Short Term Debt $13K
Total Non Current Liabilities $229K
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $1.8M
Other Non Current Liabilities $1.2K
Total Shareholder Equity $12M
Treasury Stock -
Retained Earnings -$56M
Common Stock $68M
Common Stock Shares Outstanding $18M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (EUR)
Operating Cashflow -$6.2M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $45K
Capital Expenditures $4.5K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $6.9M
Cashflow From Financing $271K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$8.9M

yearly Income Statement (As of Dec 31, 2024)

Field Value (EUR)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$9.8M
Selling General And Administrative $5M
Research And Development $4.8M
Operating Expenses $9.8M
Investment Income Net -
Net Interest Income $81K
Interest Income $81K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $45K
Income Before Tax -$8.9M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$8.9M
Comprehensive Income Net Of Tax -
Ebit -$9.8M
Ebitda -$9.7M
Net Income -$8.9M

GNTA News

GNTA Profile

Genenta Science SpA ADR Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Genenta Science SpA (GNTA) is a clinical-stage biotechnology firm based in Milan, Italy, focused on pioneering hematopoietic stem cell gene therapies to target solid tumors. The company's innovative approach leverages advanced genetic engineering techniques to potentially transform cancer treatment options. With a robust pipeline and strategic collaborations, Genenta aims to address unmet medical needs in oncology, positioning itself as a promising player in the evolving landscape of cancer therapeutics.

VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
STAI
+39.44%
$0.62
BURU
+7.15%
$0.50
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
INTC
-3.78%
$36.36
RGTI
+25.02%
$54.91
GWH
+118.14%
$9.07
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+2.94%
$16.76
DNN
+7.11%
$3.08
EPWK
-21.60%
$0.09
GPUS
-12.48%
$0.42
QBTS
+22.83%
$40.56
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
F
+1.18%
$11.54
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
PFE
-1.82%
$24.78
CRML
+55.40%
$23.28
TSLA
+5.01%
$434.23
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
ETHD
-12.95%
$3.32
RXRX
+3.94%
$5.53
NIO
+6.59%
$7.15
APLD
+0.73%
$34.24
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
QUBT
-10.81%
$19.01
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
LAES
+13.30%
$6.13
ONDS
+17.24%
$10.81
DVLT
-10.52%
$1.70
CIFR
+19.77%
$20.32
USAR
+18.61%
$38.68
MP
+21.94%
$95.52
BTBT
+5.58%
$3.97
IREN
+7.31%
$64.14
NAKA
-1.56%
$0.85
RIG
+3.73%
$3.19
WBD
-3.22%
$17.10
UAMY
+36.85%
$16.71
NOK
-1.50%
$5.24
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.14%
$25.57
RF
+1.63%
$24.55
SRM
+53.27%
$10.30
CLSK
+3.94%
$20.04
GDXD
-13.54%
$0.73
IONQ
+18.72%
$83.88
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
BMNR
+7.40%
$56.35
CLF
-7.18%
$13.18
VALE
+2.37%
$11.00
SMR
+14.72%
$45.02
MULN
-55.00%
$0.63
BINI
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RGTZ
-50.00%
$9.30
SLB
+1.71%
$32.26
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
STAI
+39.44%
$0.62
BURU
+7.15%
$0.50
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
INTC
-3.78%
$36.36
RGTI
+25.02%
$54.91
GWH
+118.14%
$9.07
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+2.94%
$16.76
DNN
+7.11%
$3.08
EPWK
-21.60%
$0.09
GPUS
-12.48%
$0.42
QBTS
+22.83%
$40.56
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
F
+1.18%
$11.54
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
PFE
-1.82%
$24.78
CRML
+55.40%
$23.28
TSLA
+5.01%
$434.23
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
ETHD
-12.95%
$3.32
RXRX
+3.94%
$5.53
NIO
+6.59%
$7.15
APLD
+0.73%
$34.24
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
QUBT
-10.81%
$19.01
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
LAES
+13.30%
$6.13
ONDS
+17.24%
$10.81
DVLT
-10.52%
$1.70
CIFR
+19.77%
$20.32
USAR
+18.61%
$38.68
MP
+21.94%
$95.52
BTBT
+5.58%
$3.97
IREN
+7.31%
$64.14
NAKA
-1.56%
$0.85
RIG
+3.73%
$3.19
WBD
-3.22%
$17.10
UAMY
+36.85%
$16.71
NOK
-1.50%
$5.24
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.14%
$25.57
RF
+1.63%
$24.55
SRM
+53.27%
$10.30
CLSK
+3.94%
$20.04
GDXD
-13.54%
$0.73
IONQ
+18.72%
$83.88
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
BMNR
+7.40%
$56.35
CLF
-7.18%
$13.18
VALE
+2.37%
$11.00
SMR
+14.72%
$45.02
MULN
-55.00%
$0.63
BINI
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RGTZ
-50.00%
$9.30
SLB
+1.71%
$32.26
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.